Deals this week: Nabriva Therapeutics, LifeMine Therapeutics, Aldeyra Therapeutics

Nabriva Therapeutics plans to raise $80m through an underwritten public offering of shares of its common stock.

Source: Drug Development Technology - September 21, 2017 Category: Pharmaceuticals Source Type: news